does the fluvoxamine label allow adult ocd doses up to 300 mg a day?
“Its label already allows adult OCD doses up to 300 milligrams a day.”
a host said on Psychopharmacology and Psychiatry Updates, 2026-10-03, at 01:41. hear it in context → the speaker cited: the fluvoxamine label.
the episode: SSRI Dosing for OCD: Beyond FDA Guidelines (at 01:41). we link the show's own page; we do not re-host audio.
first, the part that holds
the speaker is right: every current fluvoxamine label we read caps the adult ocd dose at 300 mg a day, in those exact words: "not to exceed 300 mg per day." that applies to both the immediate-release tablets and the extended-release capsules.
what we found when we went and looked
we read three current fluvoxamine labels on dailymed: two immediate-release tablet labels (revised 2/2024 and 3/2025) and one extended-release capsule label (revised 5/2025). all three set the adult ocd maximum at 300 mg per day. in the trials behind those labels, adults were titrated within a range of 100 to 300 mg a day. one detail the quote leaves out is that 300 mg is a ceiling you reach by stepping up, not a dose you start at. tablets start at 50 mg at bedtime and go up by 50 mg every 4 to 7 days as tolerated, and any total over 100 mg a day is advised to be split into two doses. capsules start at 100 mg and go up by 50 mg a week.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| the fda-approved fluvoxamine label allows adult ocd doses up to 300 mg per day | confirmed | tablet labels, section 2.1: the dose "should be increased in 50 mg increments every 4 to 7 days, as tolerated, until maximum therapeutic benefit is achieved, not to exceed 300 mg per day." the extended-release label says the same: "not to exceed 300 mg per day." limitation: we read three labels from three different labelers, not every repackager's label. all three are current and they match. [1][2][3] |
| 300 mg is a ceiling reached by titration, not a starting or standard dose | confirmed | tablets start at 50 mg at bedtime and rise by 50 mg every 4 to 7 days. the label says "a total daily dose of more than 100 mg should be given in two divided doses." extended-release capsules start at 100 mg and rise by 50 mg a week. in the trials, patients were titrated within 100 to 300 mg a day. [1][2][3] |
| the 300 mg ceiling applies to both the tablet and the extended-release capsule | confirmed | the extended-release capsule label (revised 5/2025) gives the same "not to exceed 300 mg per day" maximum for adults with ocd. it comes in 100 mg and 150 mg capsules. [3] |
| the same ceiling applies to every adult | overstated | for older adults and people with hepatic impairment, the label notes that "decreased clearance may require modified dose and titration" and advises a lower starting dose and slower titration. the 300 mg cap does not change, but the label does not treat every adult the same way on the way up. this is a side detail; the speaker did not make this claim. [1] |
both directions
for the speaker: all three labels we read use identical wording, "not to exceed 300 mg per day," for adult ocd. they cover two tablet labelers and one extended-release capsule labeler, revised between 2024 and 2025. the trial dose range in the labels, 100 to 300 mg a day, matches the ceiling the speaker cited.
against: nothing in the record contradicts the number. the only gap is framing. "allows up to 300 mg" is a ceiling reached by stepwise titration as tolerated, with doses over 100 mg a day advised to be split. the label also advises a lower start and slower titration for older adults and people with hepatic impairment. for children aged 8 to 11 the cap is lower, at 200 mg a day, but the speaker said adult doses.
what this cannot say
a label tells you what the fda approved, not what dose a particular person needs or tolerates. it also says nothing about how often doses near 300 mg are prescribed. there are many fluvoxamine labels on dailymed, mostly generics and repackagers. we read three, not all of them. we also could not extract text from the older fda-hosted pdf label, so we do not cite it. the labels themselves note that fluvoxamine has non-linear pharmacokinetics between 100 and 300 mg, so blood levels do not rise in step with the dose. the label number alone cannot tell you what that means for any one person.
sources, each one fetched and read
- dailymed (national library of medicine), fluvoxamine maleate tablet, film coated, prescribing information, revised 3/2025 What we read there: adult ocd: start at 50 mg at bedtime, increase in 50 mg steps every 4 to 7 days as tolerated, "not to exceed 300 mg per day"; daily doses over 100 mg given in two divided doses; effective range in trials 100 to 300 mg/day; ages 8 to 11 capped at 200 mg/day; older adults and people with hepatic impairment may need a modified dose and titration Fetched 2026-10-14 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=191912e6-b3c8-be1a-e063-6394a90a8dd4
- dailymed (national library of medicine), fluvoxamine maleate tablet, prescribing information, section 2.1, revised 2/2024 What we read there: "the dose should be increased in 50 mg increments every 4 to 7 days, as tolerated, until maximum therapeutic benefit is achieved, not to exceed 300 mg per day"; trial patients "were titrated within a dose range of 100 to 300 mg/day" Fetched 2026-10-14 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6eeb14df-6fcf-a737-5359-5744eb4accea
- dailymed (national library of medicine), fluvoxamine maleate extended-release capsules, prescribing information, initial u.s. approval 2008, revised 5/2025 What we read there: adult ocd: start at 100 mg at bedtime, weekly increases of 50 mg as tolerated, "not to exceed 300 mg per day"; trial patients were titrated to within 100 mg to 300 mg/day Fetched 2026-10-14 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4527a684-51c0-1858-e063-6394a90a2631&type=display
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam